DutyPills.com
Erectile Dysfunction (ED)

Caverject with liver impairment: dosing and safety

The liver is the main site of metabolism for many medications including Caverject (Alprostadil). Liver impairment slows clearance and can raise plasma levels of Alprostadil above the intended range, amplifying side effects. People with chronic liver disease, recent hepatitis or significantly raised liver enzymes need a tailored approach to Caverject at 10mcg, 20mcg, 40mcg.

Why liver function matters

Alprostadil undergoes hepatic metabolism through CYP enzymes for many medications. Reduced hepatic function slows this metabolism, prolongs the half-life and raises plasma concentrations. Alprostadil binds prostaglandin E receptors on smooth muscle of the corpus cavernosum, triggering cAMP-mediated relaxation of cavernosal smooth muscle independent of the nitric oxide pathway used by P… The prescribing information typically classifies severity by Child-Pugh score (A mild, B moderate, C severe) and gives dose adjustments accordingly.

Practical guidance

According to the prescribing information for Alprostadil, baseline liver function tests are recommended before starting Caverject in any patient with risk factors and periodically during treatment in chronic liver disease. Severe impairment (Child-Pugh C) often contraindicates Caverject or requires substantial dose reduction; mild impairment usually permits standard 10mcg, 20mcg, 40mcg with closer monitoring.

Frequently asked questions

Is Caverject safe with liver problems?

Mild liver impairment typically allows Caverject at standard or slightly reduced 10mcg, 20mcg, 40mcg with monitoring. Moderate-to-severe impairment often requires substantial dose reduction. Severe (Child-Pugh C) impairment may contraindicate Caverject entirely.

Will Caverject damage my liver?

Most Erectile Dysfunction (ED) medications at standard 10mcg, 20mcg, 40mcg doses do not harm a healthy liver. A small subset can produce drug-induced liver injury in susceptible patients, usually detected by routine ALT/AST monitoring. The prescribing information for Alprostadil lists the documented risk.

More on Caverject

The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.